Neonatal Diabetes Mellitus Around the World: Update 2024

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2024 Sep 30

PMID 39344692

Authors

Fabrizio Barbetti

Asma Deeb

Shigeru Suzuki

Affiliations

Soon will be listed here.

Abstract

Neonatal diabetes mellitus (NDM), defined as diabetes with an onset during the first 6 months of life, is a rare form of monogenic diabetes. The initial publications on this condition began appearing in the second half of the 1990s and quite surprisingly, the search for new NDM genes is still ongoing with great vigor. Between 2018 and early 2024, six brand new NDM-genes have been discovered (CNOT1, FICD, ONECUT1, PDIA6, YIPF5, ZNF808) and three genes known to cause different diseases were identified as NDM-genes (EIF2B1, NARS2, KCNMA1). In addition, NDM cases carrying mutations in three other genes known to give rise to diabetes during childhood have been also identified (AGPAT2, BSCL2, PIK3R1). As a consequence, the list of NDM genes now exceeds 40. This genetic heterogeneity translates into many different mechanism(s) of disease that are being investigated with state-of-the-art methodologies, such as induced pluripotent stem cells (iPSC) and human embryonic stem cells (hESC) manipulated with the CRISPR technique of genome editing. This diversity in genetic causes and the pathophysiology of diabetes dictate the need for a variety of therapeutic approaches. The aim of this paper is to provide an overview on recent achievements in all aspects of this area of research.

Citing Articles

Diagnosis and Treatment of Neonatal Diabetes Caused by ATP-Channel Mutations: Genetic Insights, Sulfonylurea Therapy, and Future Directions.

Trada M, Novara C, Moretto M, Burzi E, Tinti D, de Sanctis L Children (Basel). 2025; 12(2).

PMID: 40003320 PMC: 11854417. DOI: 10.3390/children12020219.

PIONEER REAL UK: A Multi-Centre, Prospective, Real-World Study of Once-Daily Oral Semaglutide Use in Adults with Type 2 Diabetes.

Saravanan P, Bell H, Braae U, Collins E, Deinega A, Dhatariya K Adv Ther. 2024; 41(11):4266-4281.

PMID: 39316289 PMC: 11480173. DOI: 10.1007/s12325-024-02973-z.

References

De Franco E . Neonatal diabetes caused by disrupted pancreatic and β-cell development. Diabet Med. 2021; 38(12):e14728. DOI: 10.1111/dme.14728. View

Suzuki S, Mukai T, Kokumai T, Furuya A, Tanahashi Y, Azuma H . Sufficient increment of sulfonylurea without reintroduction of insulin ameliorates pubertal deterioration of glycaemic control in KCNJ11 neonatal diabetes treated with long-term sulfonylurea. Diabetologia. 2020; 63(8):1659-1661. DOI: 10.1007/s00125-020-05182-9. View

Habeb A, Flanagan S, Zulali M, Abdullah M, Pomahacova R, Boyadzhiev V . Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome. Diabetologia. 2018; 61(5):1027-1036. PMC: 6449001. DOI: 10.1007/s00125-018-4554-x. View

Ngoc C, Dung V, De Franco E, Lan N, Thao B, Khanh N . Genetic Etiology of Neonatal Diabetes Mellitus in Vietnamese Infants and Characteristics of Those With Gene Mutations. Front Endocrinol (Lausanne). 2022; 13:866573. PMC: 9063464. DOI: 10.3389/fendo.2022.866573. View

Demirbilek H, Cayir A, Flanagan S, Yildirim R, Kor Y, Gurbuz F . Clinical Characteristics and Long-term Follow-up of Patients with Diabetes Due To PTF1A Enhancer Mutations. J Clin Endocrinol Metab. 2020; 105(12). PMC: 7526731. DOI: 10.1210/clinem/dgaa613. View

Piccand J, Strasser P, Hodson D, Meunier A, Ye T, Keime C . Rfx6 maintains the functional identity of adult pancreatic β cells. Cell Rep. 2014; 9(6):2219-32. PMC: 4542305. DOI: 10.1016/j.celrep.2014.11.033. View

Zhang Y, Sui L, Du Q, Haataja L, Yin Y, Viola R . Permanent neonatal diabetes-causing insulin mutations have dominant negative effects on beta cell identity. Mol Metab. 2024; 80():101879. PMC: 10839447. DOI: 10.1016/j.molmet.2024.101879. View

Miguel-Escalada I, Maestro M, Balboa D, Elek A, Bernal A, Bernardo E . Pancreas agenesis mutations disrupt a lead enhancer controlling a developmental enhancer cluster. Dev Cell. 2022; 57(16):1922-1936.e9. PMC: 9426562. DOI: 10.1016/j.devcel.2022.07.014. View

Bowden T, Letourneau-Freiberg L, Kandasamy B, Sanyoura M, Tian P, Harris A . Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry. Front Clin Diabetes Healthc. 2022; 2. PMC: 9629510. DOI: 10.3389/fcdhc.2021.735548. View

10.

Alqahtani M, Al-Qahtani S, Al-Falki Y, Alharby E, Albulym O, Almontashiri N . Biallelic loss of function variant in ZNF808 is associated with non-syndromic neonatal diabetes. Clin Genet. 2023; 104(4):497-498. DOI: 10.1111/cge.14389. View

11.

Garin I, Edghill E, Akerman I, Rubio-Cabezas O, Rica I, Locke J . Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. Proc Natl Acad Sci U S A. 2010; 107(7):3105-10. PMC: 2840338. DOI: 10.1073/pnas.0910533107. View

12.

Sahebi L, Niknafs N, Dalili H, Amini E, Esmaeilnia T, Amoli M . Iranian neonatal diabetes mellitus due to mutation in PDX1 gene: a case report. J Med Case Rep. 2019; 13(1):258. PMC: 6670147. DOI: 10.1186/s13256-019-2149-x. View

13.

Hawari I, Ericsson J, Kabeer B, Chaussabel D, Alsulaiti A, Sharari S . Understanding the Mechanism of Diabetes Mellitus in a LRBA-Deficient Patient. Biology (Basel). 2022; 11(4). PMC: 9025338. DOI: 10.3390/biology11040612. View

14.

Wanaguru A, Phan P, Lim L, Verge C, Hameed S, Neville K . Advanced hybrid closed-loop use in children less than 2 years old with diluted insulin: a case series. Acta Diabetol. 2023; 61(2):257-261. DOI: 10.1007/s00592-023-02218-5. View

15.

Busiah K, Drunat S, Vaivre-Douret L, Bonnefond A, Simon A, Flechtner I . Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]. Lancet Diabetes Endocrinol. 2014; 1(3):199-207. DOI: 10.1016/S2213-8587(13)70059-7. View

16.

Dalgin G, Tryba A, Cohen A, Park S, Philipson L, Greeley S . Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes. Sci Rep. 2021; 11(1):21590. PMC: 8566525. DOI: 10.1038/s41598-021-00939-7. View

17.

De Franco E, Owens N, Montaser H, Wakeling M, Saarimaki-Vire J, Triantou A . Primate-specific ZNF808 is essential for pancreatic development in humans. Nat Genet. 2023; 55(12):2075-2081. PMC: 10703691. DOI: 10.1038/s41588-023-01565-x. View

18.

Zhang X, McGrath P, Salomone J, Rahal M, McCauley H, Schweitzer J . A Comprehensive Structure-Function Study of Neurogenin3 Disease-Causing Alleles during Human Pancreas and Intestinal Organoid Development. Dev Cell. 2019; 50(3):367-380.e7. PMC: 7082840. DOI: 10.1016/j.devcel.2019.05.017. View

19.

Ngoc C, Dien T, De Franco E, Ellard S, Houghton J, Lan N . Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital. Front Endocrinol (Lausanne). 2021; 12:727083. PMC: 8458931. DOI: 10.3389/fendo.2021.727083. View

20.

De Franco E, Lytrivi M, Ibrahim H, Montaser H, Wakeling M, Fantuzzi F . YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress. J Clin Invest. 2020; 130(12):6338-6353. PMC: 7685733. DOI: 10.1172/JCI141455. View